Article Information
History
- September 18, 2020.
Article Versions
- Version 1 (June 5, 2020 - 22:30).
- Version 2 (June 12, 2020 - 13:54).
- You are currently viewing Version 3 of this article (September 18, 2020 - 12:48).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- ALBERTO HERNANDEZ1 (ahernandez{at}grupopoliclinica.es),
- MONTSERRAT VINALS1,
- ASUNCION PABLOS1,
- FRANCISCO VILAS1,
- PETER J PAPADAKOS2,
- DUMINDA N WIJEYSUNDERA3,
- SERGIO BERGESE4 (sergio.bergese{at}stonybrookmedicine.edu) and
- MARC VIVES5,6 (marcvives50{at}gmail.com)
- 1 Policlinica Ibiza Hospital;
- 2 University of Rochester, NY;
- 3 Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto;
- 4 Stony Brook University, New York, USA;
- 5 Hospital Universitari Dr. J Trueta de Girona
- ↵* Corresponding author; email: marcvives50{at}gmail.com
Posted September 18, 2020.
Ozone therapy for patients with COVID-19 pneumonia: a Quasi-Randomized Controlled Trial
